نمایش پرونده ساده آیتم

dc.contributor.authorGhergherehchi, R
dc.contributor.authorHabibzadeh, A
dc.date.accessioned2018-08-26T08:58:42Z
dc.date.available2018-08-26T08:58:42Z
dc.date.issued2015
dc.identifier10.3109/03630269.2014.999081
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/54726
dc.description.abstractIron overload is a common finding in chronically transfused ?-thalassemia major (?-TM) patients with possible effect on ? cell function and insulin resistance. In this study we aimed to evaluate glucose metabolism, insulin resistance and ? cell function in ?-TM patients. A total of 78 transfusion-dependant ?-TM patients and 40 age and sex matched normal children were included. Oral glucose tolerance tests (OGTT) were performed in all subjects. Fasting plasma insulin level, insulin resistance index (IRI) and ? cell function index (BFI) were also estimated. ?-Thalassemia major patients had significantly more abnormal OGTT than the control group. ?-Thalassemia major patients had significantly higher levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) fasting blood sugar and IRI than the control group. Findings between ?-thalassemia (?-thal) patients, with and without abnormal OGTT results, were also compared; ?-thal patients with abnormal OGTT had significantly higher duration of chelation therapy, serum ferritin levels, AST, ALT and increased IRI and decreased BFI in comparison to patients with normal OGTT. Abnormal glucose metabolism is common in ?-TM patients with chelation therapy and multiple transfusions which are attributable to impaired ? cells' function and increased insulin resistance. é 2015 Informa Healthcare USA, Inc.
dc.language.isoEnglish
dc.relation.ispartofHemoglobin
dc.subjectalanine aminotransferase
dc.subjectaspartate aminotransferase
dc.subjectdeferoxamine
dc.subjectferritin
dc.subjectglucose
dc.subjectinsulin
dc.subjectglucose blood level
dc.subjectinsulin
dc.subjectadolescent
dc.subjectadolescent disease
dc.subjectalanine aminotransferase blood level
dc.subjectArticle
dc.subjectaspartate aminotransferase blood level
dc.subjectblood transfusion
dc.subjectcase control study
dc.subjectcell function
dc.subjectchelation therapy
dc.subjectcomparative study
dc.subjectcontrolled study
dc.subjectdiabetes mellitus
dc.subjectdiet restriction
dc.subjecterythrocyte concentrate
dc.subjecterythrocyte transfusion
dc.subjectfemale
dc.subjectferritin blood level
dc.subjectglucose blood level
dc.subjectglucose metabolism
dc.subjecthuman
dc.subjectinsulin blood level
dc.subjectinsulin resistance
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectoral glucose tolerance test
dc.subjectpancreas islet beta cell
dc.subjectthalassemia major
dc.subjecttreatment duration
dc.subjectadverse effects
dc.subjectanalysis
dc.subjectbeta-Thalassemia
dc.subjectblood
dc.subjectchild
dc.subjectcomplication
dc.subjectglucose tolerance test
dc.subjectmetabolism
dc.subjectpancreas islet beta cell
dc.subjectpathology
dc.subjectyoung adult
dc.subjectAdolescent
dc.subjectbeta-Thalassemia
dc.subjectBlood Glucose
dc.subjectBlood Transfusion
dc.subjectCase-Control Studies
dc.subjectChelation Therapy
dc.subjectChild
dc.subjectFemale
dc.subjectGlucose Tolerance Test
dc.subjectHumans
dc.subjectInsulin
dc.subjectInsulin Resistance
dc.subjectInsulin-Secreting Cells
dc.subjectMale
dc.subjectYoung Adult
dc.titleInsulin resistance and ? cell function in patients with ?-thalassemia major
dc.typeArticle
dc.citation.volume39
dc.citation.issue1
dc.citation.spage69
dc.citation.epage73
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.3109/03630269.2014.999081


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم